Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2004-03-26
2010-06-08
Yu, Misook (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reexamination Certificate
active
07731960
ABSTRACT:
The present inventors discovered that the PepT-binding antibodies have the ability to inhibit the transport activity of peptide transporters, as a result of dedicated research. These antibodies may be utilized as cell growth inhibitors, for example, for treating and preventing cancer.
REFERENCES:
patent: 5500346 (1996-03-01), Bright et al.
patent: 5849525 (1998-12-01), Hediger
patent: 6270978 (2001-08-01), Bright et al.
patent: 6713278 (2004-03-01), Bouvier et al.
patent: 6867017 (2005-03-01), Dean et al.
patent: 2005/0004227 (2005-01-01), Saitoh
patent: 2005/0222391 (2005-10-01), Kodama et al.
patent: 2005/0281825 (2005-12-01), Kodama et al.
patent: 2006/0084119 (2006-04-01), Saitoh et al.
patent: 2006/0210569 (2006-09-01), Kodama et al.
patent: 2008/0040820 (2008-02-01), Kodama et al.
patent: 9676557 (1997-06-01), None
patent: 1142473 (2001-10-01), None
patent: 1 731 032 (2006-12-01), None
patent: 6-261761 (1994-09-01), None
patent: 8-134100 (1996-05-01), None
patent: 11-172 (1999-01-01), None
patent: 2001-197846 (2001-07-01), None
patent: 2001-139496 (2005-05-01), None
patent: 1999-0071666 (1999-09-01), None
patent: 97/19919 (1997-06-01), None
patent: WO 97/19919 (1997-06-01), None
patent: 98/46777 (1998-10-01), None
patent: 00/28016 (2000-05-01), None
patent: WO 03/033024 (2003-04-01), None
patent: 03/047621 (2003-06-01), None
patent: 03/083116 (2003-10-01), None
patent: 03/104453 (2003-12-01), None
Winter et al (Nature 1991;349:293-299).
Campbell (Monoclonal Antibody Technology; 1984; Elsevier Science Publishing Company Inc: pp. 1-33).
Liang, R. et al., “Human Intestinal H+/Peptide Cotransporter”, J. Biol. Chem., 270:6456-63 (1995).
Liu, W. et al., “Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney”, Biochim. Biophys. Acta, 1235:461-6 (1995).
Basu et al., “Development and Utility of Anti-PepT1 Anti-Peptide Polyclonal Antibodies”, Pharm. Res., 15:338-342 (1998).
Blissard et al., “Location, Sequence, Transcriptional Mapping, and Temporal Expression of the gp64 Envelope Glycoprotein Gene of theOrgyia pseudotsugataMulticapsid Nuclear Polyhedrosis Virus”, Virology, 170:537-555 (1989).
Friedman et al., “Passive and Carrier-Mediated Intestinal Absorption Components of Two Angiotensin Converting Enzyme (ACE) Inhibitor Prodrugs in Rats: Enalapril and Fosinopril”, Pharm. Res., 6:1043-1047 (1989).
Friedman et al., “Characterization of the Intestinal Transport Parameters for Small Peptide Drugs”, J. Controlled Release, 13:141-146 (1990).
Ganapathy et al., “Proton-coupled solute transport in the animal cell plasma membrane”, Curr. Opin. Cell Biol., 3:695-701 (1991).
Gonzalez et al., “An Oligopeptide Transporter is Expressed at High Levels in the Pancreatic Carcinoma Cell Lines AsPc-1 and Capan-2”, Cancer Res., 58:519-525 (1998).
Higgins, “ABC Transporters: From Microorganisms to Man”, Annu. Rev. Cell Biol., 8:67-113 (1992).
Knutter et al., “A Novel Inhibitor of the Mammalian Peptide Transporter PEPT1”, Biochemistry, 40:4454-4458 (2001).
Lee et al., “Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1”, J. Controlled Release, 62:129-140 (1999).
Lindley et al., “Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins”, J. Immunol. Methods, 234:123-135 (2000).
Loisel et al., “Recovery of homogeneous and functional β,-adrenergic receptors from extracellular baculovirus particles”, Nat Biotechnol., 12:1300-1304 (1997).
Mangor et al, “A GP64-Null Baculovirus Pseudotyped with Vesicular Stomatitis Virus G Protein”, J. Virol., 75:2544-2556 (2001).
Mikhailov et al., “Expression of functionally active ATP-sensitive K-channels in insect cells using baculovirus”, FEBS Lett., 429:390-394 (1998).
Mrsny, “Oligopeptide Transporters as Putative Therapeutic Targets for Cancer Cells”, Pharm. Res., 15:816-818 (1998).
Muranushi et al., “Transport Characteristics of Ceftibuten, a New Oral Cephem, in Rat Intestinal Brush-Border Membrane Vesicles: Relationship to Oligopeptide and Amino β-Lactam Transport”, Pharm. Res., 6:308-312.
Nakanishi et al., “Cancer Cell-Targeted Drug Delivery Utilizing Oligopeptide Transport Activity”, Int. J. Cancer, 88:274-280 (2000).
Nakashima et al., “Kinetics and Mechanism of In Vitro Uptake of Amino-β-Lactam Antibiotics by Rat Small Intestine and Relation to the Intact-peptide Transport System”, Biochem. Pharmacol., 33:3345-3352 (1984).
Noe et al., “Characterization of the Mouse Bile Salt Export Pump Overexpressed in the Baculovirus System”, Hepatology, 33:1223-1231 (2001).
Ogihara et al., “Immuno-Localization of H+/Peptide Cotransporter in Rat Digestive Tract”, Biochem. Biophys. Res. Commun., 220:848-852 (1996).
Okano et al., “H+Coupled Uphill Transport of Aminocephalosporins via the Dipeptide Transport System in Rabbit Intestinal Brush-border Membranes”, J. Biol. Chem., 261:14130-14134 (1986).
Sai et al., “Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of β-lactam antibiotics”, FEBS Lett., 392:25-29 (1996).
Sai et al., “Selective Delivery of Peptide Anticancer Drugs Via Oligopeptide Transporter Expresssed in Cancer Cells”, Millennial World Congress of Pharamaceutical Sciences, 61:2-2124 (2000).
Saito et al., “Cloning and Characterization of a Rat H+/peptide Cotransporter Mediating Absorption of β-Lactam Antibiotics in the Intestine and Kidney”, J. Pharmacol. Exp. Ther., 275:1631-1637 (1995).
Saito el al., “Molecular cloning and tissue distribution of rat peptide transporter PEPT2”, Biochim. Biophys. Acta., 1280:173-177 (1996).
Sakaguchi et al., “The Ion Channel activity of the Influenza Virus M2Protein Affects Transport through the Golgi Apparatus”, J. Cell. Biol., 133:733-747 (1996).
Satoi et al., “Genetic Immunization of Wild-Type and Hepatitis C Virus Transgenic Mice Reveals a Hierarchy of Cellular Immune Response and Tolerance Induction against Hepatitis C Virus Structural Proteins”, J. Virol., 75:12121-12127 (2001).
Shen et al., “Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney”, Am. J. Physiol., 276:F658-665 (1999).
Steiner et al., “The PTR family: a new group of peptide transporters”, Mol. Microbiol., 16:825-834 (1995).
Strehlow et al., “Retroviral membrane display of apoptotic effector molecules”, Proc. Natl. Acad. Sci. USA, 97:4209-4214 (2000).
Sugano et al., “Quantitative Structure-Intestinal Permeability Relationship of Benzamidine Analogue Thrombin Inhibitor”, Bioorg. Med. Chem. Lett. 10:1939-1942 (2000).
Sun et al., “Drug Inhibition of Gly-Sar Uptake and hPepT1 Localization using hPepT1-GFP Fusion Protein”, AAPS Pharmsci., 3:1-9 (2001).
Szakacs et al., “Characterization of the ATPase Cycle of Human ABCA1: Implications for its Function as a Regulator Rather Than an Active Transporter”, Biochem. Biophys. Res. Commun., 288:1258-1264 (2001).
Takahashi et al., “Interaction of β-Lactam Antibiotics with H+/peptide Cotransporters in Rat Renal Brush-Border Membranes”, J. Pharmacol. Exp. Ther., 286:1037-1042 (1998).
Terada et al., “Peptide Transporter Family”, Tanpakushitsu Kakusan Koso., 46:621-628 (2001) (English summary provided).
Terada et al., “Characterization of Stably Transfected Kidney Epithelial Cell Line Expressing Rat H+/Peptide Cotransporter PEPT1: Localization of PEPT1 and Transport of β-Lactam Antibiotics”, J. Pharmacol. Exp. Ther., 281:1415-1421 (1997).
Zhou et al., “Characterizationof an oligopeptide transpo
Hamakubo Takao
Kodama Tatsuhiko
Saitoh Ryoichi
Yamada Yoshiki
Chugai Seiyaku Kabushiki Kaisha
Fish & Richardson P.C.
Yu Misook
LandOfFree
Antibodies that inhibit transport activity of peptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that inhibit transport activity of peptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that inhibit transport activity of peptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245612